SciELO - Scientific Electronic Library Online

 
vol.15 número4Primary malignant bone tumours: Epidemiological data from an Orthopaedic Oncology Unit in South AfricaOrthopaedic research activity in South Africa measured by publication rates in the 15 highest impact journals related to population size and gross domestic product índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • En proceso de indezaciónSimilares en Google

Compartir


SA Orthopaedic Journal

versión On-line ISSN 2309-8309
versión impresa ISSN 1681-150X

Resumen

ZANATI, A; FERREIRA, N  y  MARAIS, LC. Giant cell tumour of bone: A demographic study from a tumour unit in South Africa. SA orthop. j. [online]. 2016, vol.15, n.4, pp.17-22. ISSN 2309-8309.  http://dx.doi.org/10.17159/2309-8309/2016/v15n4a2.

INTRODUCTION: Giant cell tumour of bone (GCT) is a rare primary bone tumour. Little is known about the epidemiology of this tumour in South Africa as most demographic information is based on research from Asia, Europe and North America. This research aims to raise awareness and promote early recognition of these tumours. Materials and methods: A retrospective analysis was conducted of all patients with biopsy-confirmed GCTs that presented between January 2010 and December 2014. Information pertaining to patient demographics, tumour location, treatment and outcome was recorded and analysed. RESULTS: Twenty-two patients were included in the study. The mean age of patients was 32.4 years (range 12-63), and a slight male predominance (1.2:1) was observed. Tumours were mainly located at the end of long bones (91%) with the distal femur and proximal tibia being most commonly affected (55%). Two patients (9%) were diagnosed with primary malignant giant cell tumours. We observed a higher rate of lung metastases (18%) than previously reported. The median tumour volume was significantly higher in patients who developed lung metastases (467.4 cm3 vs 137.8 cm3; p=0.03). Three of the patients with lung metastases were HIV-positive (odds ratio [OR] = 10.5, 95% confidence interval [CI] = 0.84-130.66, p=0.076). All patients were treated surgically with extended curettage, local adjuvant therapy, polymethyl methacrylate (PMMA) and internal fixation or en-bloc resection with prosthetic or osteochondral allograft replacement. CONCLUSION: Giant cell tumours of bone are uncommon. Demographics from South Africa emulate international statistics. No recurrence of GCTs was observed in our cohort despite the relatively large tumours at time of presentation compared to international literature that report recurrence rates of approximately 2%. The incidence of metastases and primary malignant GCT was higher than in previous reports. The association of these findings with HIV infection warrants further investigation. Metastases appear to be associated with the size of the primary tumour.

Palabras clave : giant cell tumour of bone; demography; benign tumour.

        · texto en Inglés     · Inglés ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons